MegaBuilds on MSN
I can’t believe what 2026 has in store!
Good Things Coming in 2026 0:24 The Big Clean Energy Boom 3:47 The Rise of Green Hydrogen 6:50 Europe’s New Carbon Rules 7:52 ...
Since 2019, three disease-specific therapies have been approved to treat patients with ATTR-CM. The first was Pfizer’s Vyndamax (tafamidis) in May 2019, which was approved for both wild type and ...
Silence from Scripture on new technologies and the ethical questions they raise is no excuse for silence from the church.
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...
Michael Jordan closed the Bulls dynasty in these black-and-red Air Jordan 14s. The “Last Shot” remains a Finals grail—and ...
News Medical on MSN
CIRM awards $7.4 million to advance stem cell-based gene therapy for Friedreich's ataxia
The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for ...
After more than a year of debate, NASCAR has settled on its new playoff format — a return (mostly) to the old that will be ...
The rise of antibiotic resistance has renewed interest in bacteriophages as therapeutic alternatives. However, co-evolution of phage and bacteria will naturally give rise to phage-resistant pathogens, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results